PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26021F0040Treprostinil 0.6mg ML — United Therapeutics Corp

United Therapeutics Corp holds $3.8M across 190 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 1 related award in the incumbent pipeline.

260-Network Contract Office 20 (36C260)

Awarding office

United Therapeutics Corp

Recipient

—

Estimated value

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs United Therapeutics Corp — $90

Contract facts

Federal

Contract number36C26021F0040

Also listed as36C260-21-F-0040

Agency260-Network Contract Office 20 (36C260)

Awarding office260-Network Contract Office 20 (36C260)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentUnited Therapeutics Corp

UEIKK5FBFA43JS7

PSC6505

TREPROSTINIL 0.6MG/ML is a federal award for 260-Network Contract Office 20 (36C260) held by United Therapeutics Corp. Estimated value —.

Incumbent footprint

Public record

United Therapeutics Corp — $3.8M obligated across 190 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($3.8M) · all agencies

Department of Veterans Affairs (VA)$3.7M · 97%Department of Justice (DOJ)$118K · 3%

Open full company profile →

Related awards

Same incumbent

36C26026F0064

TYVASO KITS & CARTRIDGES

$379K

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C26021F0040?

36C26021F0040 (Treprostinil 0.6mg ML) is a 260-Network Contract Office 20 (36C260) award with an estimated value of —, currently held by United Therapeutics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C260-21-F-0040?

36C260-21-F-0040 is the dashed form of PIID 36C26021F0040 (Treprostinil 0.6mg ML), held by United Therapeutics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26021F0040?

260-Network Contract Office 20 (36C260) awarded 36C26021F0040 to United Therapeutics Corp.

Who is the incumbent on 36C26021F0040?

United Therapeutics Corp is the incumbent with $3.8M across 190 related awards in SCOUT’s public footprint.

When does United Therapeutics Corp’s 36C26021F0040 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 36C26021F0040 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthly